BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 328781)

  • 1. Immune response to a mammary adenocarcinoma. IV. Blocking of cell-mediated cytolysis by immunoglobulins binding to immune lymphocytes.
    Huber SA; Lucas ZJ
    J Immunol; 1977 Aug; 119(2):726-36. PubMed ID: 328781
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune response to a mammary adenocarcinoma. VI. Blocking of tumor-specific cell-mediated cytotoxicity by antibodies to the cytotoxic lymphocyte.
    Huber SA; Lucas ZJ
    J Immunol; 1978 Dec; 121(6):2490-6. PubMed ID: 309904
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune response to a mammary adenocarcinoma. V. Sera from tumor-bearing rats contain multiple factors blocking cell-mediated cytotoxicity.
    Huber SA; Lucas ZJ
    J Immunol; 1978 Dec; 121(6):2485-9. PubMed ID: 722081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired immunological tolerance and carcinogenesis by the mammary tumor virus. II. Immune responses influencing growth of spontaneous mammary adenocarcinomas.
    Morton DL; Goldman L; Wood DA
    J Natl Cancer Inst; 1969 Feb; 42(2):321-9. PubMed ID: 4303884
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune response to a syngeneic mammary adenocarcinoma. II. In vitro generation of cytotoxic lymphocytes.
    Kuperman O; Fortner GW; Lucas ZJ
    J Immunol; 1975 Nov; 115(5):1277-81. PubMed ID: 51887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible evidence for antibody-dependent macrophage-mediated cytotoxicity directed against murine adenocarcinoma cells in vivo.
    Haskill JS; Fett JW
    J Immunol; 1976 Nov; 117(5 Pt.2):1992-8. PubMed ID: 993593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
    Lopez PF; Parks WP; Lopez DM
    J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of serum factors modifying cellular immune responses to growing tumours.
    Baldwin RW; Price MR; Robins RA
    Br J Cancer Suppl; 1973 Aug; 1():37-47. PubMed ID: 4374231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice.
    Jose DG; Good RA
    Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154
    [No Abstract]   [Full Text] [Related]  

  • 10. Differences in kinetic parameters of lysis by syngeneic and allogeneic T lymphocytes immune to the same tumor.
    Huber SA; Lucas ZJ
    J Immunol; 1978 Dec; 121(6):2270-7. PubMed ID: 309897
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor-bound immunoglobulins: their possible role in circumventing antitumor immunity.
    Witz IP; Levy HJ; Keisari Y; Izsak FC
    Johns Hopkins Med J Suppl; 1974; 3():289-300. PubMed ID: 4214276
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental solid tumors: the role of macrophages and lymphocytes as effector cells.
    Haskill JS; Radov LA; Yamamura Y; Parthenais E; Korn JH; Ritter FL
    J Reticuloendothel Soc; 1976 Sep; 20(3):233-41. PubMed ID: 1086363
    [No Abstract]   [Full Text] [Related]  

  • 13. A tumour-associated membrane antigen transiently expressed by normal cells during mitosis.
    Bertini M; Forni G; Comoglio PM
    Clin Exp Immunol; 1974 Sep; 18(1):101-8. PubMed ID: 4468189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of serial transplantation on the immunological-clinical correlates of BALB/cfC3H mouse mammary tumors.
    Hager JC; Miller FR; Heppner GH
    Cancer Res; 1978 Aug; 38(8):2492-500. PubMed ID: 667845
    [No Abstract]   [Full Text] [Related]  

  • 15. Cross-reacting tumor-associated antigen(s) of adenovirus type 9-induced fibroadenomas and a chemically induced mammary carcinoma in rats.
    Ankerst J; Steele G; Sjögren HO
    Cancer Res; 1974 Aug; 34(8):1794-800. PubMed ID: 4367178
    [No Abstract]   [Full Text] [Related]  

  • 16. Cycling of immune responses to a syngeneic murine mammary adenocarcinoma.
    Huber SA; Bigi G; Lucas ZJ
    Cancer Res; 1980 Oct; 40(10):3484-90. PubMed ID: 6449282
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor-specific suppressor cells induced by immunization with spleen cells from tumor-bearing animals.
    Huber SA; Bigi G; Lucas ZJ
    Cancer Res; 1980 Oct; 40(10):3477-83. PubMed ID: 6449281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the induction and expression of T cell-mediated immunity. II. Antiserum blocking of cell-mediated cytolysis.
    Bonavida B
    J Immunol; 1974 Apr; 112(4):1308-21. PubMed ID: 4592598
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-idiotype antibodies to the 9.1C3 blocking antibody used to probe the lethal hit stage of NK cell-mediated cytolysis.
    Werkmeister JA; Burns GF; Triglia T
    J Immunol; 1984 Sep; 133(3):1385-90. PubMed ID: 6611373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymus-derived lymphocytes as effectors of cell-mediated immunity to syngeneic and allogeneic transplants in the rat.
    Tucker DF; Dennert G; Lennox ES
    J Immunol; 1974 Oct; 113(4):1302-12. PubMed ID: 4547337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.